Article Versions Notes

Nag K, Sarker EH, Kumar S, Chakraborty S, Khan MR, Chowdhury MR, Roy R, Roy R, Biswas BK, Bappi EH, et al. Satisfying QTPP of Erythropoietin Biosimilar by QbD through DoE-Derived Downstream Process Engineering. Pharmaceutics. 2023; 15(8):2087. https://doi.org/10.3390/pharmaceutics15082087

Nag, Kakon, Enamul Haq Sarker, Samir Kumar, Sourav Chakraborty, Maksusdur Rahman Khan, Mashfiqur Rahman Chowdhury, Rony Roy, Ratan Roy, Bipul Kumar Biswas, Emrul Hasan Bappi, and et al. 2023. "Satisfying QTPP of Erythropoietin Biosimilar by QbD through DoE-Derived Downstream Process Engineering" Pharmaceutics 15, no. 8: 2087. https://doi.org/10.3390/pharmaceutics15082087

Nag, K., Sarker, E. H., Kumar, S., Chakraborty, S., Khan, M. R., Chowdhury, M. R., Roy, R., Roy, R., Biswas, B. K., Bappi, E. H., Mohiuddin, M., & Sultana, N. (2023). Satisfying QTPP of Erythropoietin Biosimilar by QbD through DoE-Derived Downstream Process Engineering. Pharmaceutics, 15(8), 2087. https://doi.org/10.3390/pharmaceutics15082087